466: Energizing the Realm of Early Stage Pharma | Jeff Farrow, CFO, Global Blood Therapeutics
An Early Dose of Pharma Start-Up Experience
When Global Blood Therapeutics CFO Jeffrey Farrow says he took the corporate-finance career path less traveled, he really means it. As an undergraduate biology major, Farrow and a couple of entrepreneurial-minded postdocs hit upon a way to identify a protein thought to cause Alzheimer’s. The group licensed the technology from the University of California system and launched their own company, “which we naively thought we maybe could take public,” Farrow recounts. He and his co-founders instead wound up selling their venture to a larger neuroscience…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.